Archives
-
MLN8237 (Alisertib): Applied Protocols for Cancer Biology Re
2026-07-24
MLN8237 (Alisertib) unlocks precise control of Aurora A kinase inhibition, enabling robust apoptosis induction in tumor models and dissecting advanced mechanisms in trained immunity. This guide translates the latest mechanistic discoveries and practical workflows into actionable protocols—optimizing your cancer biology assays with data-driven precision.
-
4-Methylumbelliferyl-β-D-Glucopyranoside: Precision Tools fo
2026-07-23
Explore the scientific foundations and advanced protocol strategies for 4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) in lysosomal enzyme activity assays. This article uniquely bridges assay optimization with emerging mRNA therapeutics for Gaucher disease.
-
Fisetin Inhibits Ferroptosis After Traumatic Brain Injury
2026-07-23
Yang et al. demonstrate that fisetin, a naturally occurring flavonoid, exerts neuroprotective effects after traumatic brain injury (TBI) by inhibiting ferroptosis and oxidative stress through PI3K/AKT/NRF2 pathway activation. This work advances understanding of ferroptosis in neurotrauma and highlights a practical in vitro approach using established ferroptosis inducers.
-
Standardized Whole-Blood Stimulation for Immunometabolic Ana
2026-07-22
This study introduces a reproducible protocol for analyzing immune responses in human whole blood under controlled metabolic modulation. Its approach enables detailed investigation of how metabolic interventions shape cytokine production, providing a robust platform for advancing immunometabolic and translational immunology research.
-
α2-Adrenergic Receptor Agonists for Immune Modulation in Ost
2026-07-22
The reference study provides compelling evidence that α2-adrenergic receptor agonists, delivered via a thermo-sensitive hydrogel, can reduce post-surgical osteosarcoma recurrence by enhancing immune-mediated tumor rejection. This research highlights a shift from direct cytotoxic strategies to immune microenvironment modulation, offering new directions for targeted bone cancer therapies.
-
Fisetin Inhibits Ferroptosis and Oxidative Stress After TBI
2026-07-21
Yang et al. (2024) demonstrate that fisetin exerts neuroprotective effects after traumatic brain injury (TBI) by inhibiting ferroptosis and oxidative stress, both in a mouse model and in cultured neural cells. Their integrative approach provides mechanistic insight into ferroptosis as a secondary injury process in TBI and highlights signaling pathways that may be targeted for therapeutic intervention.
-
Bifendate (DDB): Applied Workflows for Hepatoprotection Rese
2026-07-21
Bifendate (DDB) enables precise modeling of hepatic lipid regulation and autophagy inhibition, setting the standard for in vitro and in vivo liver disease studies. Learn how to optimize DDB usage, avoid common pitfalls, and translate mechanistic insights into robust data with confidence.
-
Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor for Apoptosis A
2026-07-20
Z-LEHD-FMK stands out as a selective, irreversible caspase-9 inhibitor, enabling precise investigation of mitochondrial apoptosis in both cancer and neuroprotection models. This article delivers protocol enhancements, troubleshooting tactics, and cross-study insights to maximize data reliability in apoptosis assays.
-
PEDV Exploits IMPDH-Dependent Nucleotide Biosynthesis for Re
2026-07-20
This study demonstrates that porcine epidemic diarrhea virus (PEDV) manipulates host IMPDH-dependent guanine nucleotide biosynthesis to enable efficient viral replication. Both genetic and pharmacological inhibition of IMPDH, including with Merimepodib (VX-497), markedly impairs viral replication, establishing IMPDH as a strategic host-targeted antiviral vulnerability.
-
CD98hc Orchestrates CNS Angiogenesis via Integrin–FAK Pathwa
2026-07-19
This study uncovers the pivotal role of CD98 heavy chain (CD98hc) in orchestrating central nervous system (CNS) angiogenesis and maintaining blood–brain barrier (BBB) integrity by locally regulating the systemic integrin–FAK pathway. The findings redefine tissue-specific vascular signaling in the CNS, providing a mechanistic basis for targeted therapies in cerebrovascular disorders.
-
Tamoxifen in Research: Applied Protocols and Troubleshooting
2026-07-18
Tamoxifen stands out as a versatile selective estrogen receptor modulator for both gene knockout and cancer research. This guide details hands-on workflows, advanced applications, and optimization strategies, using recent peer-reviewed studies and real-world lab insights.
-
Multi-Omics Mapping of ARID1A-Driven Resistance in Melanoma
2026-07-17
This study introduces an integrative multi-omics framework to define drug response networks and ARID1A-dependent resistance mechanisms in BRAF-mutant melanoma. Key findings reveal how ARID1A loss rewires signaling, sustaining MAPK pathway activity and immune evasion, and highlight critical nodes for targeting resistance.
-
Clodronate Liposomes: Precision In Vivo Macrophage Depletion
2026-07-17
Clodronate Liposomes enable targeted, reproducible in vivo macrophage depletion, providing a transformative tool for dissecting immune cell function in disease models. This guide details protocol enhancements, advanced troubleshooting, and evidence-based insights to maximize the impact of liposome-encapsulated clodronate in immunotherapy and tumor microenvironment research.
-
Targeted SPP1 Inhibition in Tumor Macrophages Reduces Tumor
2026-07-16
Kartal et al. introduce a novel nanoformulation that selectively down-regulates SPP1 expression in tumor-associated macrophages (TAM), yielding significant tumor size reduction in murine models. This work provides a new paradigm for targeting immunosuppressive TAM phenotypes and lays the groundwork for advancing combinatorial small molecule strategies in the tumor microenvironment.
-
ML133 HCl: Precision Potassium Channel Inhibitor Workflows
2026-07-16
ML133 HCl empowers researchers with selective inhibition of Kir2.1, enabling high-fidelity analysis of potassium ion transport in cardiovascular and pulmonary models. Its robust specificity and solution compatibility unlock advanced protocols for dissecting pulmonary artery smooth muscle cell behavior.